Bruce C. Cozadd
2006
In 2006, Bruce C. Cozadd earned a total compensation of $990.3K as Chairman and Chief Executive Officer at Jazz Pharmaceuticals.
Compensation breakdown
Non-Equity Incentive Plan | $77,000 |
---|---|
Option Awards | $605,818 |
Salary | $307,236 |
Other | $234 |
Total | $990,288 |
Cozadd received $605.8K in option awards, accounting for 61% of the total pay in 2006.
Cozadd also received $77K in non-equity incentive plan, $307.2K in salary and $234 in other compensation.
Rankings
In 2006, Bruce C. Cozadd's compensation ranked 3,098th out of 7,022 executives tracked by ExecPay. In other words, Cozadd earned more than 55.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,098 out of 7,022 | 56th |
Division Manufacturing | 983 out of 2,413 | 59th |
Major group Chemicals And Allied Products | 215 out of 673 | 68th |
Industry group Drugs | 134 out of 518 | 74th |
Industry Pharmaceutical Preparations | 106 out of 355 | 70th |
Source: SEC filing on October 23, 2009.
Cozadd's colleagues
We found four more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2006.
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019